News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Omixon And TBG Team Up To Provide HLA Transplant Testing In China



11/18/2016 9:28:46 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Omixon, a Budapest molecular diagnostics company, partnered with Taiwan's TBG Biotechnology to distribute and promote Omixon's Holotype HLA products in China, Hong Kong, Taiwan and Australia. Omixon's Holotype HLA genotyping products are used to assess transplantation compatability. TBG and Omixon have optimized Holotype HLA on TBG’s liquid handling DX-A Automation System, and the companies are completing a multi-site customer validation program of the liquid handling system.

Read at ChinaBio Today


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES